Table of Contents
Chemotherapy Research and Practice
Volume 2015 (2015), Article ID 316015, 16 pages
http://dx.doi.org/10.1155/2015/316015
Review Article

Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers

Department of Biology, Syracuse University, 107 College Place, Syracuse, NY 13244, USA

Received 3 May 2015; Revised 22 July 2015; Accepted 3 August 2015

Academic Editor: G. J. Peters

Copyright © 2015 Matthew Trendowski. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Trendowski, “The promise of sonodynamic therapy,” Cancer and Metastasis Reviews, vol. 33, no. 1, pp. 143–160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S.-I. Umemura, N. Yumita, and R. Nishigaki, “Enhancement of ultrasonically induced cell damage by a gallium-porphyrin complex, ATX-70,” Japanese Journal of Cancer Research, vol. 84, no. 5, pp. 582–588, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Umemura, N. Yumita, R. Nishigaki, and S.-I. Umemura, “Sonodynamically induced antitumor effect of pheophorbide a,” Cancer Letters, vol. 102, no. 1-2, pp. 151–157, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Yumita, S.-I. Umemura, N. Magario et al., “Sonodynamically-induced in vitro cell damage enhanced by adriamycin,” Cancer Letters, vol. 121, no. 2, pp. 195–201, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Yumita, S.-I. Umemura, M. Kaneuchi et al., “Sonodynamically-induced cell damage with fluorinated anthracycline derivative, FAD104,” Cancer Letters, vol. 125, no. 1-2, pp. 209–214, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Rosenthal, J. Z. Sostaric, and P. Riesz, “Sonodynamic therapy: a review of the synergistic effects of drugs and ultrasound,” Ultrasonics Sonochemistry, vol. 11, no. 6, pp. 349–363, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. W.-K. Bai, E. Shen, and B. Hu, “Induction of the apoptosis of cancer cell by sonodynamic therapy: a review,” Chinese Journal of Cancer Research, vol. 24, no. 4, pp. 368–373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Kuroki, K. Hachimine, H. Abe et al., “Sonodynamic therapy of cancer using novel sonosensitizers,” Anticancer Research, vol. 27, no. 6, pp. 3673–3677, 2007. View at Google Scholar · View at Scopus
  9. S. Mitragotri, “Healing sound: the use of ultrasound in drug delivery and other therapeutic applications,” Nature Reviews Drug Discovery, vol. 4, no. 3, pp. 255–260, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Thüroff, C. Chaussy, G. Vallancien et al., “High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study,” Journal of Endourology, vol. 17, no. 8, pp. 673–677, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Ahrar, S. Matin, C. G. Wood et al., “Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes,” Journal of Vascular and Interventional Radiology, vol. 16, no. 5, pp. 679–688, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Hecht, R. Bedford, J. L. Abbruzzese et al., “A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma,” Clinical Cancer Research, vol. 9, no. 2, pp. 555–561, 2003. View at Google Scholar · View at Scopus
  13. P. Benedetti-Panici, G. Perniola, C. Marchetti et al., “Intraperitoneal chemotherapy by ultrasound-guided direct puncture in recurrent ovarian cancer: feasibility, compliance, and complications,” International Journal of Gynecological Cancer, vol. 22, no. 6, pp. 1069–1074, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Huang, “A review of progress in clinical photodynamic therapy,” Technology in Cancer Research and Treatment, vol. 4, no. 3, pp. 283–293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. W. Miller, A. E. Luque, L. F. Battaglia, S. Mazza, and E. C. Everbach, “Biological and environmental factors affecting ultrasound-induced hemolysis in vitro: 1. HIV macrocytosis (cell size),” Ultrasound in Medicine and Biology, vol. 29, no. 1, pp. 77–91, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. N. G. Lee, J. L. Berry, T. C. Lee et al., “Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro,” Investigative Ophthalmology and Visual Science, vol. 52, no. 6, pp. 3868–3873, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Zhou, J. Cui, and C. X. Deng, “Dynamics of sonoporation correlated with acoustic cavitation activities,” Biophysical Journal, vol. 94, no. 7, pp. L51–L53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Fan, D. Chen, and C. X. Deng, “Improving ultrasound gene transfection efficiency by controlling ultrasound excitation of microbubbles,” Journal of Controlled Release, vol. 170, no. 3, pp. 401–413, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Iwanaga, K. Tominaga, K. Yamamoto et al., “Local delivery system of cytotoxic agents to tumors by focused sonoporation,” Cancer Gene Therapy, vol. 14, no. 4, pp. 354–363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. L.-F. Jin, F. Li, H.-P. Wang, F. Wei, P. Qin, and L.-F. Du, “Ultrasound targeted microbubble destruction stimulates cellular endocytosis in facilitation of adeno-associated virus delivery,” International Journal of Molecular Sciences, vol. 14, no. 5, pp. 9737–9750, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Bazan-Peregrino, B. Rifai, R. C. Carlisle et al., “Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound,” Journal of Controlled Release, vol. 169, no. 1-2, pp. 40–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Carlisle, J. Choi, M. Bazan-Peregrino et al., “Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound,” Journal of the National Cancer Institute, vol. 105, no. 22, pp. 1701–1710, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. D. R. Groothuis, “The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery,” Neuro-Oncology, vol. 2, no. 1, pp. 45–49, 2000. View at Google Scholar · View at Scopus
  24. B. A. Chabner and D. L. Longo, Cancer Chemotherapy and Biotherapy: Principles and Practice, Lippincott Williams & Wilkins, 5th edition, 2011.
  25. P. R. Lockman, R. K. Mittapalli, K. S. Taskar et al., “Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer,” Clinical Cancer Research, vol. 16, no. 23, pp. 5664–5678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Taal, H. M. Oosterkamp, A. M. E. Walenkamp et al., “Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial,” The Lancet Oncology, vol. 15, no. 9, pp. 943–953, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Tatar, E. Thivat, E. Planchat et al., “Temozolomide and unusual indications: review of literature,” Cancer Treatment Reviews, vol. 39, no. 2, pp. 125–135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. P. W. Sperduto, M. Wang, H. I. Robins et al., “A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: radiation Therapy Oncology Group 0320,” International Journal of Radiation Oncology Biology Physics, vol. 85, no. 5, pp. 1312–1318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. N. Greenspoon, W. Sharieff, H. Hirte et al., “Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study,” OncoTargets and Therapy, vol. 7, pp. 485–490, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Bhojwani and C.-H. Pui, “Intrathecal liposomal cytarabine: more friend than foe?” Leukemia and Lymphoma, vol. 49, no. 8, pp. 1427–1430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Parasole, G. Menna, N. Marra et al., “Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions,” Leukemia and Lymphoma, vol. 49, no. 8, pp. 1553–1559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Tomita, F. Kodama, H. Kanamori, S. Motomura, and Y. Ishigatsubo, “Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma,” Cancer, vol. 95, no. 3, pp. 576–580, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. W. J. Elias, D. Huss, T. Voss et al., “A pilot study of focused ultrasound thalamotomy for essential tremor,” The New England Journal of Medicine, vol. 369, no. 7, pp. 640–648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Lipsman, M. L. Schwartz, Y. Huang et al., “MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study,” The Lancet Neurology, vol. 12, no. 5, pp. 462–468, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. C.-Y. Ting, C.-H. Fan, H.-L. Liu et al., “Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment,” Biomaterials, vol. 33, no. 2, pp. 704–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Y. Xia, Z. Zhang, Y. X. Xue, P. Wang, and Y. H. Liu, “Mechanisms of the increase in the permeability of the blood-brain barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin,” Journal of Neuro-Oncology, vol. 94, no. 1, pp. 41–50, 2009. View at Google Scholar
  38. A. H. Mesiwala, L. Farrell, H. J. Wenzel et al., “High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo,” Ultrasound in Medicine and Biology, vol. 28, no. 3, pp. 389–400, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Nhan, A. Burgess, E. E. Cho, B. Stefanovic, L. Lilge, and K. Hynynen, “Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy,” Journal of Controlled Release, vol. 172, no. 1, pp. 274–280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. C. C. Chen, P. S. Sheeran, S.-Y. Wu, O. O. Olumolade, P. A. Dayton, and E. E. Konofagou, “Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets,” Journal of Controlled Release, vol. 172, no. 3, pp. 795–804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. H.-L. Liu, C.-H. Fan, C.-Y. Ting, and C.-K. Yeh, “Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview,” Theranostics, vol. 4, no. 4, pp. 432–444, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. H.-L. Liu, H.-W. Yang, M.-Y. Hua, and K.-C. Wei, “Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status,” Neurosurgical Focus, vol. 32, no. 1, article E4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. E. R. Cordeiro, X. Cathelineau, S. Thüroff, M. Marberger, S. Crouzet, and J. J. M. C. H. De La Rosette, “High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer,” BJU International, vol. 110, no. 9, pp. 1228–1242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. K. F. Chu and D. E. Dupuy, “Thermal ablation of tumours: biological mechanisms and advances in therapy,” Nature Reviews Cancer, vol. 14, no. 3, pp. 199–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Friedman, I. Mikityansky, A. Kam et al., “Radiofrequency ablation of cancer,” CardioVascular and Interventional Radiology, vol. 27, no. 5, pp. 427–434, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. S. McDermott and D. A. Gervais, “Radiofrequency ablation of liver tumors,” Seminars in Interventional Radiology, vol. 30, no. 1, pp. 49–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. M. G. Lubner, C. L. Brace, J. L. Hinshaw, and F. T. Lee Jr., “Microwave tumor ablation: mechanism of action, clinical results, and devices,” Journal of Vascular and Interventional Radiology, vol. 21, no. 8, supplement, pp. S192–S203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Jahangeer, P. Forde, D. Soden, and J. Hinchion, “Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours,” Cancer Treatment Reviews, vol. 39, no. 8, pp. 862–871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. F. Zhou, “High intensity focused ultrasound in clinical tumor ablation,” World Journal of Clinical Oncology, vol. 2, no. 1, pp. 8–27, 2011. View at Google Scholar
  50. J. E. Kennedy, “High-intensity focused ultrasound in the treatment of solid tumours,” Nature Reviews Cancer, vol. 5, no. 4, pp. 321–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Furusawa, K. Namba, H. Nakahara et al., “The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS),” Breast Cancer, vol. 14, no. 1, pp. 55–58, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. R. O. Illing, J. E. Kennedy, F. Wu et al., “The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population,” British Journal of Cancer, vol. 93, no. 8, pp. 890–895, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Lukka, T. Waldron, J. Chin et al., “High-intensity focused ultrasound for prostate cancer: a systematic review,” Clinical Oncology, vol. 23, no. 2, pp. 117–127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. A. I. So, “HIFU ablation is not a proven standard treatment for localized prostate cancer,” Journal of the Canadian Urological Association, vol. 5, no. 6, pp. 424–426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Crouzet, J. Y. Chapelon, O. Rouvière et al., “Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients,” European Urology, vol. 65, no. 5, pp. 907–914, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. L. P. Luz, M. A. Al-Haddad, M. S. L. Sey, and J. M. Dewitt, “Applications of endoscopic ultrasound in pancreatic cancer,” World Journal of Gastroenterology, vol. 20, no. 24, pp. 7808–7818, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Suzuki, A. Irisawa, and M. S. Bhutani, “Endoscopic ultrasound-guided oncologic therapy for pancreatic cancer,” Diagnostic and Therapeutic Endoscopy, vol. 2013, Article ID 157581, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. E. C. Verna and V. Dhar, “Review: endoscopic ultrasound-guided fine needle injection for cancer therapy: the evolving role of therapeutic endoscopic ultrasound,” Therapeutic Advances in Gastroenterology, vol. 1, no. 2, pp. 103–109, 2008. View at Publisher · View at Google Scholar
  59. B. M. Yan and J. Van Dam, “Endoscopic ultrasound-guided intratumoural therapy for pancreatic cancer,” Canadian Journal of Gastroenterology, vol. 22, no. 4, pp. 405–410, 2008. View at Google Scholar · View at Scopus
  60. W.-Y. Zhang, Z.-S. Li, and Z.-D. Jin, “Endoscopic ultrasound-guided ethanol ablation therapy for tumors,” World Journal of Gastroenterology, vol. 19, no. 22, pp. 3397–3403, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Sun, H. Xu, J. Xin, J. Liu, Q. Guo, and S. Li, “Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial,” Endoscopy, vol. 38, no. 4, pp. 399–403, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. H.-H. Chan, N. S. Nishioka, M. Mino et al., “EUS-guided photodynamic therapy of the pancreas: a pilot study,” Gastrointestinal Endoscopy, vol. 59, no. 1, pp. 95–99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. T. E. Yusuf, K. Matthes, and W. R. Brugge, “EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video),” Gastrointestinal Endoscopy, vol. 67, no. 6, pp. 957–961, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. S. N. Goldberg, S. Mallery, G. S. Gazelle, and W. R. Brugge, “EUS-guided radiofrequency ablation in the pancreas: results in a porcine model,” Gastrointestinal Endoscopy, vol. 50, no. 3, pp. 392–401, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Gaidhane, I. Smith, K. Ellen et al., “Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) of the pancreas in a porcine model,” Gastroenterology Research and Practice, vol. 2012, Article ID 431451, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. X. J. Wang, D. Mitchell, and T. J. Lewis, “Primary clinical use of sonodynamic therapy (SDT) for advanced breast cancer,” Journal of Clinical Oncology, vol. 26, supplement 15, abstract 12029, 2008. View at Google Scholar
  67. X. Wang, W. Zhang, Z. Xu, Y. Luo, D. Mitchell, and R. W. Moss, “Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 cases,” Integrative Cancer Therapies, vol. 8, no. 3, pp. 283–287, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. X. Wang, L. Q. Li, W. Zhang, Y. Luo, and D. G. Mitchell, “Sonodynamic and photodynamic therapy in advanced refractory breast cancer,” Journal of Clinical Oncology, vol. 30, supplement 27, abstract 118, 2012. View at Google Scholar
  69. L. Q. Li, X. Wang, I. W. Zhang, and D. Mitchell, “Primary clinical use of the sono-photo-dynamic therapy for advanced esophagocadiac and gastric adenocarcinoma,” Journal of Clinical Oncology, vol. 32, supplement, abstract e15024, 2014. View at Google Scholar
  70. M. Trendowski, “The inherent metastasis of leukaemia and its exploitation by sonodynamic therapy,” Critical Reviews in Oncology/Hematology, vol. 94, no. 2, pp. 149–163, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. T. de Witte, S. Suciu, G. Verhoef et al., “Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS,” Blood, vol. 98, no. 8, pp. 2326–2331, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Dietrich, J. Weidle, M. Rieger et al., “Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma,” Leukemia, vol. 28, no. 3, pp. 708–709, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Ramanathan and H. Skinner, “Coronary blood flow,” Continuing Education in Anaesthesia, Critical Care and Pain, vol. 5, no. 2, pp. 61–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. H. I. Bicher, F. W. Hetzel, T. S. Sandhu et al., “Effects of hyperthermia on normal and tumor microenvironment,” Radiology, vol. 137, no. 2, pp. 523–530, 1980. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Shrivastav, W. G. Kaelin Jr., W. T. Joines, and R. L. Jirtle, “Microwave hyperthermia and its effect on tumor blood flow in rats,” Cancer Research, vol. 43, no. 10, pp. 4665–4669, 1983. View at Google Scholar · View at Scopus
  76. H. Aoki, K. Kakinuma, K. Morita et al., “Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model,” International Journal of Hyperthermia, vol. 20, no. 6, pp. 595–605, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. A. M. Ponce, Z. Vujaskovic, F. Yuan, D. Needham, and M. W. Dewhirst, “Hyperthermia mediated liposomal drug delivery,” International Journal of Hyperthermia, vol. 22, no. 3, pp. 205–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. K. Morita, F. Zywietz, K. Kakinuma, R. Tanaka, and M. Katoh, “Efficacy of doxorubicin thermosensitive liposomes (40°C) and local hyperthermia on rat rhabdomyosarcoma,” Oncology Reports, vol. 20, no. 2, pp. 365–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. E. L. Jones, T. V. Samulski, M. W. Dewhirst et al., “A pilot phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma,” Cancer, vol. 98, no. 2, pp. 277–282, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. G. P. Raaphorst, J. Maio, C. E. Ng, and D. J. Stewart, “Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin,” Oncology Reports, vol. 5, no. 4, pp. 971–977, 1998. View at Google Scholar · View at Scopus
  81. J. W. J. Bergs, J. Haveman, R. Ten Cate, J. P. Medema, N. A. P. Franken, and C. Van Bree, “Effect of 41°C and 43°C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin,” Oncology Reports, vol. 18, no. 1, pp. 219–226, 2007. View at Google Scholar · View at Scopus
  82. G. A. Koning, A. M. M. Eggermont, L. H. Lindner, and T. L. M. ten Hagen, “Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors,” Pharmaceutical Research, vol. 27, no. 8, pp. 1750–1754, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. G. Kong, G. Anyarambhatla, W. P. Petros et al., “Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release,” Cancer Research, vol. 60, no. 24, pp. 6950–6957, 2000. View at Google Scholar · View at Scopus
  84. C. J. Diederich and K. Hynynen, “Ultrasound technology for hyperthermia,” Ultrasound in Medicine and Biology, vol. 25, no. 6, pp. 871–887, 1999. View at Publisher · View at Google Scholar · View at Scopus
  85. Q.-Q. Meng, B.-A. Chen, W. Wu, Z.-Y. Shao, F. Gao, and H.-H. Zhao, “Antitumor effects of low-frequency ultrasound combined with adriamycin on human leukemia multidrug resistance cell line K562/A02,” Chinese Journal of Cancer, vol. 27, no. 11, pp. 436–439, 2008. View at Google Scholar · View at Scopus
  86. Y.-Z. Zhao, C.-T. Lu, Z.-C. Zhou et al., “Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment,” Journal of Drug Targeting, vol. 19, no. 2, pp. 154–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. T. Yoshida, T. Kondo, R. Ogawa et al., “Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells,” Cancer Chemotherapy and Pharmacology, vol. 61, no. 4, pp. 559–567, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. L. Liang, S. Xie, L. Jiang, H. Jin, S. Li, and J. Liu, “The Combined effects of hematoporphyrin monomethyl ether-SDT and doxorubicin on the proliferation of QBC939 cell lines,” Ultrasound in Medicine and Biology, vol. 39, no. 1, pp. 146–160, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Trendowski, G. Yu, V. Wong, C. Acquafondata, T. Christen, and T. P. Fondy, “The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells,” Anticancer Research, vol. 34, no. 5, pp. 2195–2202, 2014. View at Google Scholar · View at Scopus
  90. M. Trendowski, V. Wong, J. N. Zoino et al., “Preferential enlargement of leukemia cells using cytoskeletal-directed agents and cell cycle growth control parameters to induce sensitivity to low frequency ultrasound,” Cancer Letters, vol. 360, no. 2, pp. 160–170, 2015. View at Publisher · View at Google Scholar
  91. M. Trendowski, J. M. Mitchell, C. M. Corsette, C. Acquafondata, and T. P. Fondy, “Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models,” Investigational New Drugs, vol. 33, no. 2, pp. 290–299, 2015. View at Publisher · View at Google Scholar · View at Scopus
  92. F. J. O'Neill, “Selective destruction of cultured tumor cells with uncontrolled nuclear division by cytochalasin B and cytosine arabinoside,” Cancer Research, vol. 35, no. 11, part 1, pp. 3111–3115, 1975. View at Google Scholar · View at Scopus
  93. M. J. Semins, B. J. Trock, and B. R. Matlaga, “The effect of shock wave rate on the outcome of shock wave lithotripsy: a meta-analysis,” Journal of Urology, vol. 179, no. 1, pp. 194–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. K. T. Pace, D. Ghiculete, M. Harju, and R. J. D. Honey, “Shock wave lithotripsy at 60 or 120 shocks per minute: a randomized, double-blind trial,” Journal of Urology, vol. 174, no. 2, pp. 595–599, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Trendowski, V. Wong, G. Yu, and T. P. Fondy, “Enlargement and multinucleation of U937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents,” Anticancer Research, vol. 35, no. 1, pp. 65–76, 2015. View at Google Scholar · View at Scopus
  96. B. Zhai, L. Chen, Y. Guo, Z. Wang, and F. Wu, “Experimental study of ultrasound on MDR in a human tumor in vivo,” Chinese Journal of Clinical Oncology, vol. 4, no. 6, pp. 390–396, 2007. View at Publisher · View at Google Scholar
  97. M. A. Kolber and P. Hill, “Vincristine potentiates cytochalasin B-induced DNA fragmentation in vitro,” Cancer Chemotherapy and Pharmacology, vol. 30, no. 4, pp. 286–290, 1992. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Mehlen and A. Puisieux, “Metastasis: a question of life or death,” Nature Reviews Cancer, vol. 6, no. 6, pp. 449–458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. D. Spano, C. Heck, P. De Antonellis, G. Christofori, and M. Zollo, “Molecular networks that regulate cancer metastasis,” Seminars in Cancer Biology, vol. 22, no. 3, pp. 234–249, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Valastyan and R. A. Weinberg, “Tumor metastasis: molecular insights and evolving paradigms,” Cell, vol. 147, no. 2, pp. 275–292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Tinkov, C. Coester, S. Serba et al., “New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization,” Journal of Controlled Release, vol. 148, no. 3, pp. 368–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. Z. Deng, F. Yan, Q. Jin et al., “Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound,” Journal of Controlled Release, vol. 174, no. 1, pp. 109–116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Todorova, V. Agache, O. Mortazavi et al., “Antitumor effects of combining metronomic chemotherapy with the antivascular action of ultrasound stimulated microbubbles,” International Journal of Cancer, vol. 132, no. 12, pp. 2956–2966, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. H. Tsuru, H. Shibaguchi, M. Kuroki, Y. Yamashita, and M. Kuroki, “Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer,” Free Radical Biology and Medicine, vol. 53, no. 3, pp. 464–472, 2012. View at Publisher · View at Google Scholar · View at Scopus
  105. D. E. Goertz, M. Todorova, O. Mortazavi et al., “Antitumor effects of combining docetaxel (taxotere) with the antivascular action of ultrasound stimulated microbubbles,” PLoS ONE, vol. 7, no. 12, Article ID e52307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. N. Yumita, N. Okuyama, K. Sasaki, and S.-I. Umemura, “Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of porfimer sodium,” Cancer Science, vol. 95, no. 9, pp. 765–769, 2004. View at Publisher · View at Google Scholar · View at Scopus
  107. Z. Gao, J. Zheng, B. Yang et al., “Sonodynamic therapy inhibits angiogenesis and tumor growth in a xenograft mouse model,” Cancer Letters, vol. 335, no. 1, pp. 93–99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Sazgarnia, A. Shanei, N. T. Meibodi, H. Eshghi, and H. Nassirli, “A novel nanosonosensitizer for sonodynamic therapy: in vivo study on a colon tumor model,” Journal of Ultrasound in Medicine, vol. 30, no. 10, pp. 1321–1329, 2011. View at Google Scholar · View at Scopus
  109. F. Nie, H.-X. Xu, M.-D. Lu, Y. Wang, and Q. Tang, “Anti-angiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: an in vivo experimental study,” Journal of Drug Targeting, vol. 16, no. 5, pp. 389–395, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Škorpíková, M. Dolníková, I. Hrazdira, and R. Janisch, “Changes in microtubules and microfilaments due to a combined effect of ultrasound and cytostatics in HeLa cells,” Folia Biologica, vol. 47, no. 4, pp. 143–147, 2001. View at Google Scholar · View at Scopus
  111. W.-S. Chen, A. A. Brayman, T. J. Matula, L. A. Crum, and M. W. Miller, “The pulse length-dependence of inertial cavitation dose and hemolysis,” Ultrasound in Medicine and Biology, vol. 29, no. 5, pp. 739–748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. H. Ando, L. B. Feril Jr., T. Kondo et al., “An echo-contrast agent, Levovist, lowers the ultrasound intensity required to induce apoptosis of human leukemia cells,” Cancer Letters, vol. 242, no. 1, pp. 37–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  113. X. Su, P. Wang, X. Wang, B. Cao, L. Li, and Q. Liu, “Apoptosis of U937 cells induced by hematoporphyrin monomethyl ether-mediated sonodynamic action,” Cancer Biotherapy and Radiopharmaceuticals, vol. 28, no. 3, pp. 207–217, 2013. View at Publisher · View at Google Scholar · View at Scopus